Persistence with stroke prevention medications 3 months after hospitalization

Archives of Neurology

Volumn 67, Issue 12, 2010, Pages 1456-1463

  Bushnell, Cheryl D ^a   Zimmer, Louise O ^b   Pan, Wenqin ^b   Olson, DaiWai M ^b   Zhao, Xin ^b   Meteleva, Tatiana ^b   Schwamm, Lee ^d   Ovbiagele, Bruce ^e   Williams, Linda ^f   LaBresh, Kenneth A ^c   Peterson, Eric D ^b  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c RTI INTERNATIONAL   (United States)

^d HARVARD UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; WARFARIN;

ADULT; AGE; AGED; ARTICLE; AWARENESS; BRAIN ISCHEMIA; COHORT ANALYSIS; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; GEOGRAPHIC DISTRIBUTION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; INSURANCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SECONDARY PREVENTION; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; UNITED STATES; WORK DISABILITY;

AGED; COHORT STUDIES; FACTOR ANALYSIS, STATISTICAL; FEMALE; HOSPITALIZATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; OBSESSIVE BEHAVIOR; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; RECURRENCE; SECONDARY PREVENTION; STROKE;

EID: 78650144757     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.190     Document Type: Article

References (19)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al; Writing Group Members; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association [published correction appears in Circulation. 2010;121(12):e260]. Circulation. 2010;121(7):e46-e215. doi: 369 10.1161/CIRCULATIONAHA.1109.192667.
2. Ovbiagele B, Saver JL, Fredieu A, et al. In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke. 2004;35(12):2879-2883. (Pubitemid 39565188)
3. Rahiman A, Saver JL, Porter V, et al. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months. J Stroke Cerebrovasc Dis. 2008;17(1):5-8.
4. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166(17):1842-1847. (Pubitemid 44455166)
5. De Schryver EL, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A; Dutch TIA trial and SPIRIT study groups. Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke. J Neurol. 2005;252(11):1316- 1321. (Pubitemid 41699020)
6. Daugherty SL, Ho PM, Spertus JA, et al. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med. 2008;168(5):485-491. (Pubitemid 351547211)
7. Gehi AK, Ali S, Na B, Whooley MA. Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study. Arch Intern Med. 2007;167(16):1798-1803. (Pubitemid 47403069)
8. Bushnell C, Zimmer L, Schwamm L, et al; AVAIL registry. The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) registry: design, rationale, and baseline patient characteristics. Am Heart J. 2009;157(3):428-435.
9. Wilson JT, Hareendran A, Grant M, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin Scale. Stroke. 2002;33(9):2243-2246. (Pubitemid 35014637)
10. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life: the EuroQol Group. Health Policy. 1990;16(3):199-208.
11. Kroenke K, Spitzer R. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32:1-7.
12. Williams LS, Brizendine EJ, Plue L, et al. Performance of the PHQ-9 as a screening tool for depression after stroke. Stroke. 2005;36(3):635-638. (Pubitemid 40344169)
13. Pit SW, Byles JE, Cockburn J. Accuracy of telephone self-report of drug use in older people and agreement with pharmaceutical claims data. Drugs Aging. 2008;25(1):71-80.
14. Otsuki M, Clerisme-Beaty E, Rand C, Riekert K. Measuring adherence to medication regimens in clinical care and research. In: Shumaker S, Ockene J, Riekert K, eds. The Handbook of Health Behavior Change. 3rd ed. New York, NY: Springer; 2009:309-325.
15. Ovbiagele B, Kidwell CS, Selco S, Razinia T, Saver JL. Treatment adherence rates one year after initiation of a systematic hospital-based stroke prevention program. Cerebrovasc Dis. 2005;20(4):280-282. (Pubitemid 41318207)
16. Hillen T, Dundas R, Lawrence E, Stewart JA, Rudd AG, Wolfe CD. Antithrombotic and antihypertensive management 3 months after ischemic stroke : a prospective study in an inner city population. Stroke. 2000;31(2):469-475. (Pubitemid 30078184)
17. Glader EL, Sjölander M, Eriksson M, Lundberg M. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41(2):397-401. doi:10.1161/STROKEAHA.1109.566950.
18. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC. Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke. 2001;32(8):1884-1889. (Pubitemid 32772225)
19. Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113(24):2803-2809. (Pubitemid 44305292)